Market
AI-designed mRNA cancer vaccine in US clinical trials by mid-2025?
2
Resolution / Starting Odds
Yes • 50%
No • 50%
Clinical trial registries or reputable news sources
Story
Oracle CEO Larry Ellison Announces AI-Designed mRNA Cancer Vaccines in 48 Hours at White House, Calls AI Our Best Shot at a Cure
Jan 21, 2025, 11:29 PM
Larry Ellison, CEO of Oracle, announced at the White House that artificial intelligence (AI) will soon be capable of designing personalized mRNA vaccines for cancer patients within 48 hours. This initiative, part of a broader project referred to as Project Starship, aims to leverage AI for early cancer detection and the development of tailored vaccine therapies. Ellison emphasized the potential of AI to revolutionize healthcare, enabling faster drug discovery and personalized treatment options. He stated, "AI is our best shot at a cure," highlighting the importance of gene sequencing in the process of creating these vaccines. The announcement reflects a growing commitment to harnessing technology in the fight against cancer.
View original story
Similar markets
Oracle • 25%
Pfizer • 25%
Moderna • 25%
Other • 25%
Other • 25%
Oracle • 25%
Moderna • 25%
BioNTech • 25%
Prostate Cancer • 25%
Other • 25%
Lung Cancer • 25%
Breast Cancer • 25%
Other • 25%
United States • 25%
United Kingdom • 25%
Germany • 25%
China • 25%
EU • 25%
USA • 25%
Other • 25%
No • 50%
Yes • 50%
United Kingdom • 25%
United States • 25%
Other • 25%
Germany • 25%
Successful with minor issues • 25%
Trials delayed • 25%
Unsuccessful • 25%
Successful with no major issues • 25%